In this video, Steven Grinspoon, MD, talks about the overall take-home messages from his session Mechanisms and Treatments for Steatosis in HIV, including what's next for research on this topic.
In this video, Steven Grinspoon, MD, talks about why treatments for steatosis in HIV are important to study, including some reasons why most studies in nonalcoholic fatty liver disease (NAFLD) do not...
In this video, Steven Grinspoon, MD, talks about why treatments for steatosis in HIV are important to study, including some reasons why most studies in nonalcoholic fatty liver disease (NAFLD) do not...
In this video, W. Clay Jackson, MD, DipTh, talks about expanding medical services to patients during the COVID-19 pandemic using telehealth, including lighting, licensing, and "linking" patient visits. ...
In this video, Steven Grinspoon, MD, speaks about effective treatments of steatosis in patients with HIV, including whether tesamorelin could decrease liver fat in men and women living with HIV and...
In this video, Steven Grinspoon, MD, speaks about effective treatments of steatosis in patients with HIV, including whether tesamorelin could decrease liver fat in men and women living with HIV and...
In this video, Steven Grinspoon, MD, talks about the association between HIV and Steatosis and why patients with HIV are at an increased risk of steatosis.
In this video, Steven Grinspoon, MD, talks about the association between HIV and Steatosis and why patients with HIV are at an increased risk of steatosis.
In this video, Steven Grinspoon, MD, talks about his session Mechanisms and Treatments of Steatosis in HIV at the Conference on Retroviruses and Opportunistic Infections 2021, including the reasons why...
In this video, Steven Grinspoon, MD, talks about his session Mechanisms and Treatments of Steatosis in HIV at the Conference on Retroviruses and Opportunistic Infections 2021, including the reasons why...
